Genetic Identification of Two Novel Loci Associated with Steroid-Sensitive Nephrotic Syndrome.


Journal

Journal of the American Society of Nephrology : JASN
ISSN: 1533-3450
Titre abrégé: J Am Soc Nephrol
Pays: United States
ID NLM: 9013836

Informations de publication

Date de publication:
08 2019
Historique:
received: 28 10 2018
accepted: 22 04 2019
pubmed: 3 7 2019
medline: 28 4 2020
entrez: 3 7 2019
Statut: ppublish

Résumé

Steroid-sensitive nephrotic syndrome (SSNS), the most common form of nephrotic syndrome in childhood, is considered an autoimmune disease with an established classic HLA association. However, the precise etiology of the disease is unclear. In other autoimmune diseases, the identification of loci outside the classic HLA region by genome-wide association studies (GWAS) has provided critical insights into disease pathogenesis. Previously conducted GWAS of SSNS have not identified non-HLA loci achieving genome-wide significance. In an attempt to identify additional loci associated with SSNS, we conducted a GWAS of a large cohort of European ancestry comprising 422 ethnically homogeneous pediatric patients and 5642 ethnically matched controls. The GWAS found three loci that achieved genome-wide significance, which explain approximately 14% of the genetic risk for SSNS. It confirmed the previously reported association with the HLA-DR/DQ region (lead single-nucleotide polymorphism [SNP] rs9273542, Because

Sections du résumé

BACKGROUND
Steroid-sensitive nephrotic syndrome (SSNS), the most common form of nephrotic syndrome in childhood, is considered an autoimmune disease with an established classic HLA association. However, the precise etiology of the disease is unclear. In other autoimmune diseases, the identification of loci outside the classic HLA region by genome-wide association studies (GWAS) has provided critical insights into disease pathogenesis. Previously conducted GWAS of SSNS have not identified non-HLA loci achieving genome-wide significance.
METHODS
In an attempt to identify additional loci associated with SSNS, we conducted a GWAS of a large cohort of European ancestry comprising 422 ethnically homogeneous pediatric patients and 5642 ethnically matched controls.
RESULTS
The GWAS found three loci that achieved genome-wide significance, which explain approximately 14% of the genetic risk for SSNS. It confirmed the previously reported association with the HLA-DR/DQ region (lead single-nucleotide polymorphism [SNP] rs9273542,
CONCLUSIONS
Because

Identifiants

pubmed: 31263063
pii: ASN.2018101054
doi: 10.1681/ASN.2018101054
pmc: PMC6683715
doi:

Substances chimiques

Androgen-Binding Protein 0
CALHM6 protein, human 0
Calcium Channels 0
Epitopes 0
HLA-DQ alpha-Chains 0
HLA-DQ beta-Chains 0
HLA-DRB1 Chains 0
Membrane Glycoproteins 0
PARM-1 protein, human 0
Peptides 0
Steroids 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1375-1384

Subventions

Organisme : Medical Research Council
ID : G1002528
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : R01 DK094987
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK098135
Pays : United States
Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

Copyright © 2019 by the American Society of Nephrology.

Références

Immunol Lett. 2000 Apr 3;72(1):23-30
pubmed: 10789677
Nature. 2007 Jun 7;447(7145):661-78
pubmed: 17554300
Nat Rev Genet. 2010 Jul;11(7):499-511
pubmed: 20517342
Immunol Lett. 2011 Jun 30;137(1-2):1-8
pubmed: 21262263
N Engl J Med. 2011 Feb 17;364(7):616-26
pubmed: 21323541
Pediatr Nephrol. 2012 Jun;27(6):873-83
pubmed: 21617915
Immunol Today. 1990 Aug;11(8):274-7
pubmed: 2206271
Nat Genet. 2012 Mar 25;44(5):502-10
pubmed: 22446964
Curr Opin Immunol. 2012 Oct;24(5):571-5
pubmed: 23017373
Nat Genet. 2013 Jun;45(6):580-5
pubmed: 23715323
PLoS One. 2013 Jun 06;8(6):e64683
pubmed: 23762245
Science. 2014 Mar 7;343(6175):1246949
pubmed: 24604202
Trials. 2014 Apr 27;15:147
pubmed: 24767719
Hum Genet. 2014 Jun;133(6):727-35
pubmed: 24770875
Hum Mol Genet. 2014 Dec 20;23(25):6927-34
pubmed: 25082827
Nat Genet. 2014 Nov;46(11):1187-96
pubmed: 25305756
J Am Soc Nephrol. 2015 Jul;26(7):1701-10
pubmed: 25349203
PLoS One. 2014 Dec 05;9(12):e113318
pubmed: 25478796
Gigascience. 2015 Feb 25;4:7
pubmed: 25722852
Pflugers Arch. 2016 Mar;468(3):395-403
pubmed: 26603282
Cytokine Growth Factor Rev. 2016 Oct;31:27-35
pubmed: 27235091
Nephrol Dial Transplant. 2016 Feb 4;32(2):325-332
pubmed: 27333618
Mol Biol Evol. 2016 Oct;33(10):2555-64
pubmed: 27436009
Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1760-1768
pubmed: 27445165
Nat Rev Nephrol. 2016 Sep;12(9):549-62
pubmed: 27477491
Int Rev Immunol. 2016 Sep 19;:1-11
pubmed: 27645024
Gene. 2017 Jan 15;597:66-75
pubmed: 27784631
Clin J Am Soc Nephrol. 2017 Feb 7;12(2):332-345
pubmed: 27940460
J Am Soc Nephrol. 2017 Jul;28(7):2158-2166
pubmed: 28209808
J Am Soc Nephrol. 2018 Jul;29(7):2000-2013
pubmed: 29903748
Lancet. 2018 Jul 7;392(10141):61-74
pubmed: 29910038
J Am Soc Nephrol. 2018 Aug;29(8):2189-2199
pubmed: 30012571
Am J Hum Genet. 2018 Aug 2;103(2):232-244
pubmed: 30057032
Am J Hum Genet. 2018 Sep 6;103(3):338-348
pubmed: 30100085
Nat Med. 2018 Nov;24(11):1721-1731
pubmed: 30275566
Lancet. 1974 Sep 7;2(7880):556-60
pubmed: 4140273

Auteurs

Stephanie Dufek (S)

Department of Renal Medicine and.

Chris Cheshire (C)

Department of Renal Medicine and.

Adam P Levine (AP)

Department of Renal Medicine and.

Richard S Trompeter (RS)

Department of Renal Medicine and.

Naomi Issler (N)

Department of Renal Medicine and.

Matthew Stubbs (M)

Department of Renal Medicine and.

Monika Mozere (M)

Department of Renal Medicine and.

Sanjana Gupta (S)

Department of Renal Medicine and.

Enriko Klootwijk (E)

Department of Renal Medicine and.

Vaksha Patel (V)

Great Ormond Street Hospital, London, United Kingdom.

Daljit Hothi (D)

Great Ormond Street Hospital, London, United Kingdom.

Aoife Waters (A)

Great Ormond Street Hospital, London, United Kingdom.

Hazel Webb (H)

Great Ormond Street Hospital, London, United Kingdom.

Kjell Tullus (K)

Great Ormond Street Hospital, London, United Kingdom.

Lucy Jenkins (L)

Great Ormond Street Hospital, London, United Kingdom.

Lighta Godinho (L)

Great Ormond Street Hospital, London, United Kingdom.

Elena Levtchenko (E)

University Hospitals Leuven and University of Leuven, Leuven, Belgium.

Jack Wetzels (J)

Nephrology, Radboud University Medical Center, Nijmegen, The Netherlands.

Nine Knoers (N)

Department of Genetics, UMC Groningen, Groningen, The Netherlands.

Nynke Teeninga (N)

Department of Pediatric Nephrology, Erasmus University Medical Centre-Sophia Children's Hospital, Rotterdam, The Netherlands.

Jeroen Nauta (J)

Department of Pediatric Nephrology, Erasmus University Medical Centre-Sophia Children's Hospital, Rotterdam, The Netherlands.

Mohamed Shalaby (M)

Pediatric Nephrology Center of Excellence, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.

Sherif Eldesoky (S)

Pediatric Nephrology Center of Excellence, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.

Jameela A Kari (JA)

Pediatric Nephrology Center of Excellence, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.

Shenal Thalgahagoda (S)

Department of Paediatrics, University of Peradeniya, Peradeniya, Sri Lanka.

Randula Ranawaka (R)

Department of Paediatrics, University of Peradeniya, Peradeniya, Sri Lanka.

Asiri Abeyagunawardena (A)

Department of Paediatrics, University of Peradeniya, Peradeniya, Sri Lanka.

Adebowale Adeyemo (A)

NHGRI, National Institutes of Health, Bethesda, Maryland.

Mark Kristiansen (M)

University College London Genomics, Institute of Child Health, University College London, London, United Kingdom.

Rasheed Gbadegesin (R)

Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina; and.

Nicholas J Webb (NJ)

Department of Paediatric Nephrology and.
NIHR Manchester Clinical Research Facility, Manchester Academic Health Science Centre, Royal Manchester Children's Hospital, Manchester, United Kingdom.

Daniel P Gale (DP)

Department of Renal Medicine and.

Horia C Stanescu (HC)

Department of Renal Medicine and.

Robert Kleta (R)

Department of Renal Medicine and r.kleta@ucl.ac.uk d.bockenhauer@ucl.ac.uk.

Detlef Bockenhauer (D)

Department of Renal Medicine and r.kleta@ucl.ac.uk d.bockenhauer@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH